Cargando…
Consequence of the introduction of routine FCH PET/CT imaging for patients with prostate cancer: a dual centre survey
BACKGROUND: Fluorocholine(18F) (FCH) was introduced at the beginning of April 2010 in France, Slovenia and three other EU member states for the localisation of bone metastases of prostate cancer with PET. The aim of the study was to compare the evolution of diagnostic imaging in patients with prosta...
Autores principales: | Hodolic, Marina, Michaud, Laure, Huchet, Virginie, Balogova, Sona, Nataf, Valérie, Kerrou, Khaldoun, Vereb, Marika, Fettich, Jure, Talbot, Jean-Noël |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Association of Radiology and Oncology
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3908843/ https://www.ncbi.nlm.nih.gov/pubmed/24587775 http://dx.doi.org/10.2478/raon-2013-0049 |
Ejemplares similares
-
Incidental uptake of (18)F-fluorocholine (FCH) in the head or in the neck of patients with prostate cancer
por: Hodolic, Marina, et al.
Publicado: (2014) -
(18)F-Fluorodihydroxyphenylalanine vs other radiopharmaceuticals for imaging neuroendocrine tumours according to their type
por: Balogova, Sona, et al.
Publicado: (2013) -
A Pilot Comparison of (18)F-fluorocholine PET/CT, Ultrasonography and (123)I/(99m)Tc-sestaMIBI Dual-Phase Dual-Isotope Scintigraphy in the Preoperative Localization of Hyperfunctioning Parathyroid Glands in Primary or Secondary Hyperparathyroidism: Influence of Thyroid Anomalies
por: Michaud, Laure, et al.
Publicado: (2015) -
The Presence of an Arteria Lusoria Should Be Checked When Reporting (18)F-FCH PET/CT Performed to Localize Hyperfunctioning Parathyroid Glands
por: Talbot, Jean-Noël, et al.
Publicado: (2023) -
(18)F-fluorocholine PET/CT in patients with occult biochemical recurrence of prostate cancer: Detection rate, impact on management and adequacy of impact. A prospective multicentre study
por: Gillebert, Quentin, et al.
Publicado: (2018)